STAT

DECEMBER 20, 2023

Plus, Jason Mast pops in to give an update on Uniqure’s puzzling approach to presenting trial results. Today, we get into why Amy Abernethy is leaving Verily, and why the ongoing reckoning with AI doesn’t necessarily need the voice of Google to chime in. Read the rest…

Vaccines 363

Vaccines Drug Pricing Drug Development 363

STAT

JUNE 13, 2024

In a presentation in London about vaccine development, Berkley, the former CEO of Gavi, the Vaccine Alliance, raised the issue of H5N1 bird flu when discussing whether the world was ready for another pandemic following its experience with Covid-19.

Vaccines 364

Vaccines 364

STAT

NOVEMBER 21, 2022

Last Thursday in JAMA Oncology, Northwest Biotherapeutics and its scientific collaborators published the results of a large clinical trial showing its personalized cancer vaccine administered to patients with brain tumors reduced the risk of death by 20% compared to a group of patients taken from “external controls.”

Vaccines 261

Vaccines 261

STAT

SEPTEMBER 18, 2024

At the recent annual International AIDS Conference, a startling presentation about the newest wonder drug in HIV prevention brought a raucous standing ovation. After years of failed vaccine trials, this was something nearly as valuable — a shot given twice yearly that substantially prevents HIV infections.

Vaccines 363

Vaccines 363

STAT

JUNE 20, 2024

In a surprise move, Doctors Without Borders is closing down its access-to-medicines campaign, which has been credited with ensuring needed drugs and vaccines have been made available to countless patients in low-income countries around the world. A strategic plan for the new structure is not finalized, though, according to sources.

Vaccines 363

Vaccines 363

STAT

OCTOBER 4, 2024

We know there is nothing more important than being fully present. ” “I’ve had a cough since starting that new medication,” “I’m traveling to Vietnam next week, do I need any vaccines?” ” Read the rest…

Vaccines 323

Vaccines 323

STAT

JANUARY 22, 2025

The EU moved swiftly after the Covid pandemic emerged in 2020 to secure vaccines for member countries to buy for their citizens and residents, but many aspects of the procurement from Pfizer have been kept confidential, leading to claims of a lack of transparency and several legal proceedings.

Compounding 266

Compounding Vaccines 266

STAT

OCTOBER 6, 2023

Despite the remarkable success in development of vaccines to prevent severe disease from SARS-CoV-2, it remains unclear how SARS-CoV-2, a newly emerging virus, causes such a broad spectrum of disease , ranging from asymptomatic and mild cases to severe disease and death. Read the rest…

Immunization 347

Immunization Immunity Vaccines 347

STAT

JANUARY 17, 2023

Whatever your schedule, we hope you are feeling invigorated and inspired, because the ever-present to-do list is, no doubt, expanding. Merck made J&J vaccines at only one plant, but did not make commercial   doses at another plant involved a more complex part of the manufacturing process. And of course, do stay in touch.

Vaccines 235

Vaccines Drug Pricing 235

STAT

DECEMBER 12, 2024

Such a medicine, if proven effective, would be the closest thing to a vaccine the HIV field has produced in four decades of research.   They will present that data next year. The The company plans to begin the trial next year, with an eye toward regulatory filings in late 2027.

Drug Pricing 248

Drug Pricing Vaccines 248

STAT

DECEMBER 4, 2023

The administration launched the rare disease pilot program, dubbed START and modeled after the record race for a Covid-19 vaccine, this September. Peter Marks, head of the Center for Biologics Evaluation and Research, has spearheaded both initiatives. ’” Continue to STAT+ to read the full story…

Vaccines 350

Vaccines 350

Express Pharma

JANUARY 15, 2025

Indian Immunologicals in collaboration with the Department of Animal Husbandry and Dairying, Government of India and NDDB conducted a Conclave on Pandemic Preparedness & Vaccine Innovation in Hyderabad. India is known as a vaccine hub of the world and more than 60 per cent of the vaccines for the world is manufactured in India.

Vaccines 102

Vaccines 102

STAT

FEBRUARY 22, 2023

This year’s flu shot generated relatively robust levels of protection, new data show, with the vaccine’s effectiveness ranging between about 45% and 55%, depending on the age group and the metric studied, such as whether there was protection against any infection or infection that was severe enough to require hospitalization.

Immunization 246

Immunization Immunity Hospitals Vaccines 246

STAT

OCTOBER 8, 2024

So join us as we hoist the ever-present cup of stimulation — our choice today is coconut rum — and attack the fast-growing to-do list. A group of doctors and medical practices claimed they overpaid for the vaccine, which was the only mumps shot in the U.S. We trust you have your own hectic agendas. ” A U.S.

Compounding 244

Compounding Compounding Pharmacies Vaccines Immunity 244

ALiEM - Pharm Pearls

JANUARY 12, 2024

A 42-year old Bengali man with a history of hyperlipidemia presented to the Emergency Department with facial swelling, diffuse rash, renal insufficiency and proteinuria after receiving his COVID-19 vaccine (Moderna) booster dose. He presented to his primary care physician three days later.

Vaccines 130

Vaccines 130

pharmaphorum

JULY 18, 2022

MBA, managing director at CanSino Biologics Europe, tells us about Convidecia, a single dose SARS-CoV-2 vaccine offered as an injectable and inhalant that allows ease of storage, an alternative option for individuals with needle phobias, and robust elongated CD4 and CD8 cellular response. Morgon, PharmD, LL.M, How it works.

Vaccines 138

Vaccines Health and Personal Care Stores Immunity Immunization 138

Pharmaceutical Business Review

SEPTEMBER 16, 2024

This vaccine is intended for individuals aged 12 and above and is now stocked at pharmacies including CVS Pharmacy, Walgreens, Rite Aid among others. The vaccine has been granted Emergency Use Authorization by the US Food and Drug Administration on 30 August 2024. Our vaccine targets JN.1, 1.1.” “Our vaccine targets JN.1,

Vaccines 111

Vaccines Independent Pharmacies 111

pharmaphorum

MARCH 16, 2021

European regulators questioned the integrity of early batches of Pfizer/BioNTech’s mRNA vaccine, although the matter was resolved before approval, according to information leaked online following a cyberattack. As it conducted its analysis of the vaccine in December, the European Medicines Agency’s systems were targeted by unknown hackers.

Vaccines 138

Vaccines Documentation 138

Pharmaceutical Technology

MAY 11, 2023

Results published in Nature for a personalised pancreatic cancer vaccine that uses neoantigens from patients’ tumours have lent further support to early positive signals. The vaccine, developed by BioNTech, led to half of the patients with pancreatic cancer in the Phase I trial remaining cancer-free 18 months later.

Vaccines 138

Vaccines Immunity Immunization 138

European Pharmaceutical Review

MARCH 6, 2023

The first clinical trial of any subunit tuberculosis (TB) vaccine in a temperature-stable form has found that ID93+GLA-SE, a freeze-dried vaccine, was safe. The recombinant subunit vaccine is made from four proteins of Mycobacterium tuberculosis bacteria combined with GLA-SE, an immune-stimulating adjuvant.

Immunization 103

Immunization Immunity Vaccines Communication 103

STAT

MAY 14, 2024

The drugmaker presented the new long-term data on Tuesday at the European Congress on Obesity in Venice, Italy, in a new analysis from a large study for which substantial results had been published last year. made vaccine was tested in clinical trials but never approved for use. An American woman who took part in the U.S. where the U.K-made

Vaccines 246

Vaccines 246

Express Pharma

AUGUST 27, 2024

Bharat Biotech (BBIL) has launched HILLCHOL (BBV131), an oral cholera vaccine developed under license from Hilleman Laboratories. To meet global demand, Bharat Biotech has established large-scale manufacturing facilities in Hyderabad and Bhubaneswar with a capacity to produce up to 200 million doses of the vaccine annually.

Vaccines 111

Vaccines 111

European Pharmaceutical Review

APRIL 25, 2023

The R21/Matrix-M malaria vaccine, developed by the University of Oxford , has been approved for use in Ghana (13 April 2023) and was authorised for use in Nigeria on 17 April. How does the R21/Matrix-M vaccine work? This technology has been used successfully in Novavax’s COVID-19 vaccine.

Vaccines 111

Vaccines Immunity Immunization 111

pharmaphorum

SEPTEMBER 10, 2020

The programme is still in the early stages of development, but if it works in trials would provide another approach to prevent transmission of SARS-CoV-2, the virus that causes COVID-19, alongside vaccines and prophylactic antibodies. subtilis spores engineered to present SARS-CoV-2 antigens to the mucosal immune system.

Vaccines 133

Vaccines Adverse Reactions Immunization Immunity 133

pharmaphorum

DECEMBER 4, 2020

Valneva has said it plans to accelerate research into its Lyme disease vaccine candidate VLA15, bringing forward a trial including children into the first quarter of 2021. Pfizer will pay up to $45 million in development related milestone payments and up to $143 million if the vaccine hits early sales targets.

Vaccines 119

Vaccines Immunity Immunization 119

Express Pharma

JANUARY 22, 2025

The award was presented during a ceremony at Hotel Ritz Carlton, Pune, on January 21, 2025, in the presence of Chief Guest Dr R A Mashelkar, a scientist and Padma Vibhushan awardee. We took a significant personal and financial risk to ensure the vaccine’s safety and efficacy, even taking early doses ourselves before licensure.

Vaccines 109

Vaccines Pharmaceutical Companies Pharmaceutical Companies 109

Express Pharma

AUGUST 27, 2024

Indian Immunologicals Limited (IIL) has announced the development of a live-attenuated, needle-free intranasal booster vaccine against SARS-CoV-2. The vaccine was created using codon deoptimization technology in collaboration with Griffith University, Australia. The danger due to COVID-19 is still not over.

Vaccines 104

Vaccines Immunization Immunity Communication 104

European Pharmaceutical Review

JUNE 13, 2023

If approved, VLA1553 could become the first licensed chikungunya vaccine” A single vaccination of VLA1553 has been shown to produce neutralising antibody levels, thought to protect against chikungunya disease in 99 percent of Phase III trial participants. What did the chikungunya vaccine study results show?

Immunization 105

Immunization Immunity Vaccines 105

European Pharmaceutical Review

MARCH 26, 2024

Moderna’s next-generation COVID-19 vaccine mRNA-1283 demonstrated a higher immune response against SARS-CoV-2, interim results from the company’s Phase III trial show. These findings were based on data comparing the treatment to mRNA-1273.222 (Spikevax ® ), Moderna’s licensed vaccine for the condition. Moderna’s Spikevax XBB.1.5-adapted

Vaccines 110

Vaccines Immunization Immunity 110

pharmaphorum

MARCH 2, 2021

Zebra Technologies healthcare lead Chris Sullivan discusses the COVID-19 vaccine rollout and how technology can streamline the process to combat new variants. . While the rollout of the COVID-19 vaccine has signified the first signs of light at the end of the tunnel, the reality is that this public health crisis is still far from over.

Vaccines 119

Vaccines Adverse Reactions Documentation Labelling 119

STAT

SEPTEMBER 19, 2023

So join us as we hoist the ever-present cup of stimulation — our choice today is glazed doughnut — and attack the fast-growing to-do list. Moderna accuses them of infringing three patents covering its revolutionary mRNA vaccine technology used to create the Covid-19 vaccine.

Vaccines 233

Vaccines 233

pharmaphorum

MAY 10, 2021

Coronavirus won’t be circulating in the UK by August, according to the outgoing chief of the country’s vaccine rollout scheme, Dr Clive Dix. He told the newspaper that the country is on track to meet its target of giving at least one shot of coronavirus vaccine to all adults by the end of July.

Vaccines 124

Vaccines 124

Express Pharma

SEPTEMBER 26, 2023

Indian Institute of Technology Mandi researchers, led by Dr Amit Prasad, Associate Professor, School of Biosciences and Bioengineering, has made strides in the development of vaccines against the pork tapeworm (T. Traditionally, tapeworm vaccines have been developed using products or antigens derived from tapeworm eggs or larvae.

Vaccines 111

Vaccines Immunization Immunity Hospitals 111

World Pharma News

OCTOBER 9, 2023

NYSE: PFE) will present data across its infectious disease portfolio at the upcoming IDWeek 2023 held in Boston from October 11-15, 2023. Pfizer Inc. Data from 45 abstracts will highlight the advances Pfizer is making in helping prevent and treat certain infectious diseases, particularly respiratory illnesses.

Vaccines 99

Vaccines Immunization Immunity 99

European Pharmaceutical Review

DECEMBER 2, 2022

Vaccines Europe has unveiled its first pipeline review of its 15 members companies, with 100 vaccine candidates as of July 2022. . The data indicated 46 percent of the vaccine candidates target infections that do not have an available vaccine. Establish digital vaccination registries to improve vaccination coverage rates.

Vaccines 98

Vaccines Immunity Immunization 98

STAT

OCTOBER 21, 2024

 The discordant trial results, presented on Oct. The deal would allow Sanofi to focus on its more lucrative, but riskier, innovative drugs and vaccines, and CD&R to take a 50% controlling stake in a business that is home to brands such as Allegra, Dulcolax, and IcyHot. billion, including debt , The Wall Street Journal writes.

Vaccines 273

Vaccines Communication 273

Pharmaceutical Technology

NOVEMBER 28, 2024

The EC has granted approval for presentation of GSK's Menveo vaccine (MenACWY) for invasive meningococcal disease (IMD).

Vaccines 52

Vaccines 52